Basic Search
|
Summaries
|
Advanced Search
Violation Tracker Current Parent Company Summary
Current Parent Company Name: Hikma Pharmaceuticals
Ownership Structure: publicly traded
Headquartered in: United Kingdom
Major Industry: pharmaceuticals
Specific Industry: pharmaceuticals
Penalty total since 2000: $456,034,479
Number of records: 10
| Top 5 Offense Groups (Groups Defined) | Penalty Total | Number of Records |
| government-contracting-related offenses | $306,014,000 | 8 |
| healthcare-related offenses | $150,000,000 | 1 |
| safety-related offenses | $20,479 | 1 |
| Top 5 Primary Offense Types | Penalty Total | Number of Records |
| False Claims Act and related | $306,014,000 | 8 |
| off-label or unapproved promotion of medical products | $150,000,000 | 1 |
| workplace safety or health violation | $20,479 | 1 |
Notes: Parent-subsidiary linkages are based on relationships current as of the latest revision listed in the
Update Log, which may vary from what was the case when a violation occurred. The penalty totals are adjusted to account for the fact that the individual entries below may include both agency records and settlement announcements for the same case; or else a penalty covering multiple locations may be listed in the individual records for each of the facilities. The totals are also adjusted to reflect cases in which federal and state or local agencies cooperated and issued separate announcements of the outcome. Duplicate or overlapping penalty amounts are marked with an asterisk in the list below.
Links: Subsidy Tracker data on financial assistance to this company by federal, state and local government agencies can be found
here.
Individual Penalty Records:
Click on the company or penalty amount for more information on each case.
| Company | Primary Offense Type | Year | Agency | Penalty Amount  |
| Roxane Laboratories Inc. | False Claims Act and related | 2010 | DOJ_CIVIL | $280,000,000 |
| Hikma Pharmaceuticals | off-label or unapproved promotion of medical products | 2024 | MULTI-AG | $150,000,000 |
| Roxanne Laboratories and Boehringer Ingelheim | False Claims Act and related | 2008 | AL-AG | $9,500,000 |
| Roxane Laboratories, Inc. | False Claims Act and related | 2009 | FL-AG | $8,500,000 |
| Roxane, Inc. | False Claims Act and related | 2010 | MO-AG | $3,100,000 |
| Roxane Laboratories Inc. | False Claims Act and related | 2009 | OH-AG | $2,400,000 |
| Boehringer Ingelheim Roxane, Inc. | False Claims Act and related | 2008 | MA-AG | $1,800,000 |
| Boehringer Ingelheim Roxane, Inc. et al. | False Claims Act and related | 2009 | IA-AG | $357,000 |
| Roxane Laboratories, Inc. | False Claims Act and related | 2009 | IA-AG | $357,000 |
| HIKMA PHARMACEUTICALS | workplace safety or health violation | 2020 | OSHA | $20,479 |
